Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,961 CHF | +0.38% | -0.45% | +13.69% |
Apr. 25 | Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15 | DP |
Apr. 25 | Symrise disappoints despite strong sales growth | DP |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company returns high margins, thereby supporting business profitability.
- Sales forecast by analysts have been recently revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 37.17 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.95% | 39.61B | B+ | ||
+13.43% | 64.32B | A- | ||
-4.02% | 45.95B | A- | ||
+20.84% | 25.74B | A- | ||
+8.52% | 18.75B | C+ | ||
-0.60% | 17.23B | B+ | ||
-21.03% | 15.86B | A- | ||
+1.21% | 15.03B | B+ | ||
-17.64% | 13.99B | C+ | ||
-23.90% | 13.09B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GIVN Stock
- Ratings Givaudan SA